LD-2 disclosure · 3rd Quarter - Report
HORIZON PHARMA USA, INC
Client
- Description
- Biopharmaceutical development
- Location
- Illinois · United States of America
Registrant
- Description
- consultant lobbying
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
H.R. 6, legislation to address opioids manufacturing and distribution Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), vaccines and other various provisions.
LobbyistsCHARLES M BRAIN · mr A. J. WOJCIAK · HEATHER MCHUGH · BEAU` SCHUYLER
Covered position (CHARLES M BRAIN): Special Assistant to the President, Deputy Chief of Staff House Ways & Means Committee
Covered position (mr A. J. WOJCIAK): Senior Legislative Aide to Rep. Earl Pomeroy
Covered position (HEATHER MCHUGH): Legislative Director to Senator Charles Schumer
Covered position (BEAU` SCHUYLER): Legislative Director to Rep. John Tanner
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R. 4710, 340B PAUSE Act, establishing a moratorium on the registration of new 340B hospitals and associated sites, and requiring reporting of program data. H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to manufacturers share of cost-sharing for Medicare beneficiaries in the donut hole phase of Part D plan coverage.
LobbyistsCHARLES M BRAIN · mr A. J. WOJCIAK · HEATHER MCHUGH · BEAU` SCHUYLER
Covered position (CHARLES M BRAIN): Special Assistant to the President, Deputy Chief of Staff House Ways & Means Committee